Development of first prototype device for exhale nitric oxide

Project: Research project

Project Details

Description

Development of first prototype device for exhale nitric oxide Development of first prototype device for exhale nitric oxide Rez-CheckTM will address the asthma market by introducing a pocketsize device for detection of eNO and BT. At present there is only one comparable (football-size) eNO device, Niox Mino, by Aerocrine. The device received FDA approval 510(k) in 20081-3, which paves the way for FDA approval of Rez-CheckTM product. It is based on electrochemical detection (Niox Mino). Another reported device uses proteins for eNO detection (e.g. InsightTM). The use of wet chemistry (e.g., electrolytes and proteins) and need of accurate reference potential in these devices make them complicated and expensive, but also unstable (short shelf-life) and difficult to store and shifting. More importantly, the electrochemical detection is prone to interferents present in human breath, which often lead to false positive. Rez-CheckTM uses a simpler solid-state technology involving no wet chemistry or proteins.
StatusFinished
Effective start/end date11/11/1012/10/12

Funding

  • INDUSTRY: Foreign Company: $673,387.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.